Semler Scientific/$SMLR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Semler Scientific
Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test. also invest in bitcoin and have adopted bitcoin as its treasury reserve asset. Company's healthcare technology solutions business is predominant operational focus, providing cash flows and enabling it to pursue bitcoin.
Ticker
$SMLR
Sector
Primary listing
Employees
79
Headquarters
Website
SMLR Metrics
BasicAdvanced
$420M
7.21
$3.94
1.40
-
Price and volume
Market cap
$420M
Beta
1.4
52-week high
$81.56
52-week low
$21.77
Average daily volume
527K
Financial strength
Current ratio
0.596
Quick ratio
0.444
Long term debt to equity
25.105
Total debt to equity
25.105
Interest coverage (TTM)
2.67%
Profitability
EBITDA (TTM)
5.405
Gross margin (TTM)
90.84%
Net profit margin (TTM)
86.20%
Operating margin (TTM)
12.10%
Effective tax rate (TTM)
17.02%
Revenue per employee (TTM)
$540,000
Management effectiveness
Return on assets (TTM)
1.07%
Return on equity (TTM)
16.04%
Valuation
Price to earnings (TTM)
7.207
Price to revenue (TTM)
6.012
Price to book
1.01
Price to tangible book (TTM)
1.01
Price to free cash flow (TTM)
21.214
Free cash flow yield (TTM)
4.71%
Free cash flow per share (TTM)
1.338
Growth
Revenue change (TTM)
-30.39%
Earnings per share change (TTM)
94.26%
3-year revenue growth (CAGR)
-7.54%
10-year revenue growth (CAGR)
25.44%
3-year earnings per share growth (CAGR)
34.48%
10-year earnings per share growth (CAGR)
13.39%
What the Analysts think about SMLR
Analyst ratings (Buy, Hold, Sell) for Semler Scientific stock.
Bulls say / Bears say
Semler’s Bitcoin treasury strategy has amassed 5,021 BTC valued at $586.2 million as of July 31, 2025, generating $110.4 million in unrealized gains and a 31.3% BTC yield YTD, underscoring its success in augmenting shareholder value via crypto asset appreciation (PR Newswire).
The core healthcare business delivered income from operations of $20.9 million for the full year 2024, demonstrating profitable cash flows that underpin both ongoing R&D and the Bitcoin acquisition strategy (PR Newswire).
In January 2025, Semler issued $100 million of 4.25% convertible senior notes due 2030, enhancing liquidity and financial flexibility to fund both healthcare innovation initiatives and continued Bitcoin purchases without immediate cash outlays (PR Newswire).
Core healthcare revenue fell 43% year-over-year to $8.2 million in Q2 2025, missing consensus estimates and highlighting persistent weakness in the company’s primary business segment (Nasdaq).
Semler sold 2,197,988 shares under its ATM program for net proceeds of approximately $119.6 million in 2024, a potentially dilutive action that may pressure the stock and existing shareholder value (PR Newswire).
Semler has ceased marketing QuantaFlo for heart dysfunction and faces no guarantee of obtaining a new FDA 510(k) clearance for expanded indications, creating regulatory uncertainty that could impede future revenue growth (SEC Form 10-Q, Q1 2025).
Data summarised monthly by Lightyear AI. Last updated on 2 Sept 2025.
SMLR Financial Performance
Revenues and expenses
SMLR Earnings Performance
Company profitability
SMLR News
AllArticlesVideos
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Semler Scientific
Business Wire1 week ago
Deadline Alert: Semler Scientific Inc. (SMLR) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Business Wire2 weeks ago
Deadline Approaching: Semler Scientific Inc. (SMLR) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Business Wire2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Semler Scientific stock?
Semler Scientific (SMLR) has a market cap of $420M as of September 16, 2025.
What is the P/E ratio for Semler Scientific stock?
The price to earnings (P/E) ratio for Semler Scientific (SMLR) stock is 7.21 as of September 16, 2025.
Does Semler Scientific stock pay dividends?
No, Semler Scientific (SMLR) stock does not pay dividends to its shareholders as of September 16, 2025.
When is the next Semler Scientific dividend payment date?
Semler Scientific (SMLR) stock does not pay dividends to its shareholders.
What is the beta indicator for Semler Scientific?
Semler Scientific (SMLR) has a beta rating of 1.4. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.